Company Monitoring Page for Takeda

latest headlines for company on cafepharma

Despite Vyvanse's loss of exclusivity, Takeda treads water thanks to launch momentum
Fierce Pharma
Fri, 02/2/24 - 11:43 am
Tags:
Takeda, ADHD, Vyvanse, earnings
Takeda grabs late-stage hematology drug from Protagonist
Pharmaphorum
Thu, 02/1/24 - 11:20 am
Tags:
Takeda, hematology, Protagonist Therapeutics, polycythemia vera
Five years after Shire deal, Takeda looks to reap rewards of latest reinvention
BioPharma Dive
Fri, 01/19/24 - 11:12 am
Tags:
Takeda, M&A, Shire, fruquintinib, Exkivity
Top 5 Life Science Companies Hiring Remote
BioSpace
Thu, 01/18/24 - 11:12 am
Tags:
remote work, hirings, Takeda, AbbVie, Moderna Therapeutics, Biomarin, CSL Behring
Takeda Gets FDA Label Expansion for HyQvia in Rare Autoimmune Disorder
BioSpace
Wed, 01/17/24 - 08:27 pm
Tags:
Takeda, FDA, HyQvia, demyelinating polyneuropathy
JPM 24: How Takeda beat 'almost every biopharmaceutical company' to win Nimbus’ TYK2 med
Fierce Biotech
Thu, 01/11/24 - 11:17 am
Tags:
Takeda, TAK-279, Nimbus Therapeutics, JPMHC 2024
Drugmakers set to raise US prices on at least 500 drugs in January
Reuters
Tue, 01/2/24 - 09:59 am
Tags:
drug pricing, Pfizer, Sanofi, Takeda
Takeda’s gene therapy pivot leaves JCR behind after proof-of-concept preclinical test
Fierce Biotech
Thu, 12/21/23 - 09:57 am
Tags:
Takeda, gene therapy, JCR Pharma
Takeda’s Fruzaqla (Fruquintinib) Gets FDA Nod for Metastatic Colorectal Cancer
Xtalks
Thu, 12/21/23 - 09:42 am
Tags:
Takeda, FDA, colorectal cancer, fruquintinib, Fruzaqla
Takeda snares approval for all-comer gastric cancer drug
Medical Marketing and Media
Sun, 11/12/23 - 09:23 pm
Tags:
Takeda, Fruzaqla, colorectal cancer
Takeda Wins First FDA Approval for Ultra-Rare Blood Clotting Disease
BioSpace
Fri, 11/10/23 - 10:12 am
Tags:
Takeda, FDA, ADAMTS13, Adzynma, cogenital thrombocytopenic purpura
Takeda Wins FDA Approval for Fruquintinib in Certain Colorectal Cancer Patients
BioSpace
Thu, 11/9/23 - 09:48 am
Tags:
Takeda, fruquintinib, FDA, colorectal cancer
Tricks and Treats as Biopharma’s Q3 Earnings Season Gets Underway
BioSpace
Sun, 10/29/23 - 08:53 pm
Tags:
earnings, Bristol Myers Squibb, Takeda, Novartis, Sanofi, Merck
Novartis claims ex-staffer jumped to Takeda with 'thousands' of sensitive files
Fierce Pharma
Thu, 10/26/23 - 10:52 pm
Tags:
Novartis, Takeda, trade secrets
Takeda Reports $770M Write-Down, Cuts Profit Forecast by 71% for FY2023
BioSpace
Thu, 10/26/23 - 10:47 pm
Tags:
Takeda, earnings
Takeda’s stem cell treatment Alofisel flunks phase 3 trial in Crohn's complication
Fierce Pharma
Thu, 10/19/23 - 10:07 am
Tags:
Takeda, Crohn's Disease, Alofisel, clinical trials, stem cells
Takeda ponies up €130M to settle tax linked to distant AbbVie-Shire breakup fee
Fierce Pharma
Wed, 10/18/23 - 07:37 pm
Tags:
Takeda, AbbVie, Shire, M&A, legal
Takeda to Withdraw Oncology Drug Exkivity from U.S. Market
Managed Healthcare Executive
Tue, 10/3/23 - 10:34 am
Tags:
Takeda, Exkivity, clinical trials, non-small cell lung cancer
Path for BrainStorm ALS Treatment Remains Rocky, Hope for Others on Horizon
BioSpace
Sun, 10/1/23 - 01:05 pm
Tags:
FDA, BrainStorm Cell Therapeutics, NurOwn, Seelos Therapeutics, Takeda, Clene
Takeda’s Entyvio receives FDA approval for subcutaneous administration
Pharmaceutical Technology
Thu, 09/28/23 - 11:46 pm
Tags:
Takeda, Entyvio, ulcerative colitis, FDA

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.